EcoDrugPlus

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSMAMG00000019076
Gene Symbol: CDK9
2 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSMAMG00000014790
Gene Symbol: CYSLTR1
3 Cross references
176 Possible Orthologues:

Cytidine Deaminase-Like

Ensembl ID : ENSMAMG00000009232
Gene Symbol: LOC113129974
3 Cross references
200 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSMAMG00000020776
Gene Symbol: LOC113135526
2 Cross references
194 Possible Orthologues:

Cytochrome P450 3a27-Like

Ensembl ID : ENSMAMG00000009612
Gene Symbol: LOC113145499
2 Cross references
445 Possible Orthologues:

Cytochrome P450 3a40-Like

Ensembl ID : ENSMAMG00000008375
Gene Symbol: LOC113127855
2 Cross references
549 Possible Orthologues:

Cytochrome P450 3a56-Like

Ensembl ID : ENSMAMG00000022004
Gene Symbol: LOC113131583
2 Cross references
535 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSMAMG00000002830
Gene Symbol: CYP19A1
3 Cross references
244 Possible Orthologues:

Death Associated Protein 3

Ensembl ID : ENSMAMG00000014708
Gene Symbol: DAP3
2 Cross references
251 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1a

Ensembl ID : ENSMAMG00000015394
Gene Symbol: DGAT1A
3 Cross references
191 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1b

Ensembl ID : ENSMAMG00000011382
Gene Symbol: DGAT1B
3 Cross references
190 Possible Orthologues:

Dihydroorotate Dehydrogenase

Ensembl ID : ENSMAMG00000001638
Gene Symbol: DHODH
3 Cross references
172 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).